4//SEC Filing
GLECKEL LOUIS MD 4
Accession 0001493152-21-014017
CIK 0000868278other
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 4:05 PM ET
Size
5.7 KB
Accession
0001493152-21-014017
Insider Transaction Report
Form 4
GLECKEL LOUIS MD
10% Owner
Transactions
- Award
Option (right to buy)
2021-06-09+100,000→ 100,000 totalExercise: $5.28Exp: 2028-06-09→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The transaction reported in this row involves a grant by the Issuer to the Reporting Person of a stock option to purchase the Issuer's common stock, with one-quarter of such stock option vesting on June 30, 2021 and the remaining portion vesting pro rata in equal monthly installments beginning July 31, 2021 and on the last day of each month thereafter, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of June 9, 2021.
Documents
Issuer
ProPhase Labs, Inc.
CIK 0000868278
Entity typeother
Related Parties
1- filerCIK 0001164762
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 4:05 PM ET
- Size
- 5.7 KB